Identification of key genes for cuproptosis in carotid atherosclerosis

Xize Wu1,2, Jian Kang2, Xue Pan2,3

  • 1Department of Critical Care Medicine, Nantong Hospital of Traditional Chinese Medicine, Nantong Hospital Affiliated to Nanjing University of Chinese Medicine, Nantong, Jiangsu, China.

PubMed

Insights

Cuproptosis influences the carotid atherosclerosis (CAS) immune microenvironment and actin cytoskeleton. This study identifies key genes and develops a nomogram for predicting CAS incidence and plaque stability.

Area of Science:

  • Cardiovascular Biology
  • Molecular Pathology
  • Genomics

Background:

  • Atherosclerosis, a global cardiovascular disease, includes carotid atherosclerosis (CAS) as a major cause of stroke.
  • Emerging research links cuproptosis, a cell death pathway, to increased risk of atherosclerotic cardiovascular disease.
  • Understanding the molecular mechanisms connecting cuproptosis and CAS is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the potential mechanisms linking cuproptosis to carotid atherosclerosis (CAS).
  • To identify key genes and pathways involved in cuproptosis-related CAS.
  • To develop a predictive model for CAS incidence and plaque stability.

Main Methods:

  • Integrated gene expression datasets (GSE100927, GSE43292) to identify CAS differentially expressed genes (DEGs).
  • Intersected CAS DEGs with cuproptosis-related genes to identify CAS cuproptosis-related genes (CASCRGs).
  • Employed unsupervised clustering, weighted gene co-expression network analysis, and machine learning (Lasso + XGBoost) for gene screening and nomogram construction.

Main Results:

  • Identified four ASCRGs (NLRP3, SLC31A2, CDKN2A, GLS) regulating the CAS immune microenvironment.
  • Discovered two distinct cuproptosis-related molecular clusters in CAS samples.
  • Validated SGCE, PCDH7, RAB23, and RIMKLB as hub genes, with SGCE and PCDH7 serving as biomarkers for CAS plaque stability.

Conclusions:

  • Cuproptosis significantly alters the immune infiltration microenvironment in carotid atherosclerosis.
  • Cuproptosis may play a regulatory role in actin cytoskeleton formation within CAS.
  • A developed nomogram demonstrates satisfactory predictive performance for CAS incidence.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...